Biodesix, Inc. BDSX 深 沪
等待开盘 05-12 09:30:00 美东时间
16.11
+1.130
+7.54%
华盛通- 最 高16.41
- 今 开15.18
- 成交量 10.82万股
- 最 低 14.38
- 昨 收 14.98
- 总市值 64.10万
- 52周最高 20.21
- 市盈率 静 --
- 换手率 271.81%
- 52周最低 0.25
- 委 比 81.82%
- 总股本 3.98万
- 历史最高 31.99
- 量 比 0.75
- 振 幅 13.55%
- 历史最低 0.1718
- 每 手 1
- 风险率 5.44%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多Earnings Scheduled For May 4, 2026
Companies Reporting Before The Bell • Pulse Biosciences (NASDAQ:PLSE) is likely...
05-04 19:11
William Blair Upgrades Biodesix to Outperform
William Blair analyst Brian Weinstein upgrades Biodesix (NASDAQ:BDSX) from Market Perform to Outperform.
02-28 05:43
Earnings Scheduled For February 26, 2026
Companies Reporting Before The Bell • Enovis (NYSE:ENOV) is estimated to report...
02-26 19:11
Market-Moving News for January 12th
XOM: -1.5% | Trump 'Inclined' To Keep Exxon Mobil Out Of Venezuela: 'Didn't Like Their Response' BDSX: 46% | Biodesix Sees Q4 Revenue $28.8M, FY2025 Revenue $88.5M, Up 41% and 24% YoY CRML: 15% |
01-12 20:29
Earnings Scheduled For November 3, 2025
Companies Reporting Before The Bell • CNA Financial (NYSE:CNA) is expected to r...
2025-11-03 19:11
Biodesix Partners with Association of Pulmonary Advanced Practice Providers (APAPP) to Deliver Nation’s First Medical Education for APPs on Biomarkers in Lung Nodule and Lung Cancer Programs
Biodesix and APAPP collaborate to launch educational programs on diagnostic tools for lung cancer, aiming to improve patient care and outcomes.
2025-06-10 10:17
燃石医学盘中异动 快速上涨7.28%报7.32美元
北京时间2025年01月25日03时38分，燃石医学（BNR.us）股票出现异动，股价大幅上涨7.28%。截至发稿，该股报7.32美元/股，成交量231股，换手率0.00%，振幅0.00%。 最近的财报数据显示，该股实现营业收入17.95百万美元，净利润-4.99百万美元，每股收益-0.48美元，毛利12.81百万美元，市盈率-1.18倍。 机构评级方面，目前暂无机构对该股做出“买入、持有、卖出”建议。 燃石医学股票所在的生命科学行业中，整体涨幅为0.00%。其相关个股中，Prenetics Global Limited C/Wts 18/05/2027 (To Pur Com)、Bioaff...
2025-01-25 03:38
Scotiabank Initiates Coverage On Biodesix with Sector Outperform Rating, Announces Price Target of $3
Scotiabank analyst Sung Ji Nam initiates coverage on Biodesix (NASDAQ:BDSX) with a Sector Outperform rating and announces Price Target of $3.
2024-09-17 01:56
